ECDC Europa

ECDC Europa

Latest Posts

Transmission of monkeypox virus clade I: overall risk remains low in the EU/EEA​
Mpox: Infection prevention and control​
Acute respiratory infections in the EU/EEA: epidemiological update and current public health recommendations – winter 2024/2025​
Communicable disease threats report, 7-13 December 2024, week 50​
The European Union One Health 2023 Zoonoses report​
Communicable disease threats report, 16-22 November 2024, week 47​
Surveillance of West Nile virus infections in humans, weekly report​
Communicable disease threats report, 9-15 November 2024, week 46​
Joint ECDC-EFSA rapid outbreak assessment – Prolonged multi-country outbreak of Salmonella Strathcona ST2559 linked to consumption of tomatoes in the EU/EEA and the UK​
Communicable disease threats report, 2-8 November 2024, week 45​
The European Respiratory Virus Surveillance Summary (ERVISS)​
Communicable disease threats report, 22-28 March 2025, week 13​
Weekly respiratory virus update, week 12, March 2025​
COVID-19 vaccination reduces risk of ‘long COVID’ in adults​
Does COVID-19 vaccination reduce the risk and duration of post COVID-19 condition?​
Communicable disease threats report, 15 – 21 March 2025, week 12​
Weekly respiratory virus update, week 11, March 2025​
Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020​
External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021​
External quality assessments on COVID-19​